Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans

scientific article

Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.12.3.318
P698PubMed publication ID1547191

P2093author name stringJ L Witztum
S Parthasarathy
W F Beltz
P D Reaven
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectlipoproteinQ28350
P304page(s)318-324
P577publication date1992-03-01
P1433published inArteriosclerosis and thrombosis : a journal of vascular biologyQ27709770
P1476titleEffect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans
P478volume12

Reverse relations

cites work (P2860)
Q40418236Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action
Q41154272Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system
Q35088538Clinical results with AGI-1067: a novel antioxidant vascular protectant
Q42547365Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial
Q36055271Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro
Q36199705Glucose Starvation Alters Heat Shock Response, Leading to Death of Wild Type Cells and Survival of MAP Kinase Signaling Mutant.
Q34234638Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
Q41615081Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis
Q77522059Medical therapies for the prevention of restenosis after percutaneous coronary interventions
Q77718601Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis
Q42436911Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment
Q72753424Positive correlation between probucol in low density lipoprotein and LDL-lowering
Q42542905The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation
Q78004684The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881

Search more.